Disclosed are agents that inhibit histone deacetylase. More specifically, the present invention relates to novel hydroxamic acid derivatives or pharmaceutically acceptable salts thereof for anticancer agents or other therapeutic agents based on their histone deacetylase inhibitory activity.

 
Web www.patentalert.com

< Polynucleotides encoding novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections

> Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use

> Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque
~ 00500